More importantly, we provide in vitro evidence that LiTE-Me acts as a light-inducible bispecific T cell engager (BiTE), allowing spatiotemporal control with light of tumor cell killing by CD8+ effector T cells. The gene discussed is CD8A; the disease is neoplasm.